Literature DB >> 8613681

ERCC1/ERCC4 5'-endonuclease activity as a determinant of hypoxic cell radiosensitivity.

D Murray1, A Macann, J Hanson, E Rosenberg.   

Abstract

In this study, the relationships between cellular oxygen enhancement ratios (OER) and nucleotide excision repair capability were examined using the UV20 mutant cell line (which has a defective ERCC1 gene). Using a clonogenic survival assay, the OER for the killing of wild-type AA8 cells was 3.2 +/- 0.1, whereas that for UV20 cells was only 2.35 +/- 0.05; the decreased OER of UV20 cells was the result of their significantly greater radiosensitivity relative to wild-type cells under hypoxic conditions. In AA8 cells, hypoxia protected against DNA double-strand break (dsb) induction (determined by pulsed-field gel electrophoresis) by a factor 3.5 +/- 0.3; i.e. to a similar extent that it modulated cell killing. However, this correlation was not apparent in UV20 cells, where hypoxia protected against dsb induction to a similar extent as in wild-type cells (approximately 3.2-fold). Stably transfected UV20 cells over-expressing a full-length ERCC1 cDNA clone displayed a normal OER (3.5 +/- 0.1) in addition to wild-type resistance to UV light. Our data suggest that the hypoxic radiosensitivity of UV20 cells is a direct result of their ERCC1 deficiency and reflects their inability to process some type of DNA damage (not dsbs) that is induced preferentially in hypoxic cells.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8613681     DOI: 10.1080/095530096145878

Source DB:  PubMed          Journal:  Int J Radiat Biol        ISSN: 0955-3002            Impact factor:   2.694


  7 in total

1.  Involvement of the Ras/extracellular signal-regulated kinase signalling pathway in the regulation of ERCC-1 mRNA levels by insulin.

Authors:  W Lee-Kwon; D Park; M Bernier
Journal:  Biochem J       Date:  1998-04-15       Impact factor: 3.857

2.  Role of excision repair cross-complementation 1 expression as a prognostic marker for response to radiotherapy in early-stage laryngeal cancer.

Authors:  Kimberly Johung; Amar Rewari; Hao Wu; Benjamin Judson; Joseph N Contessa; Bruce G Haffty; Roy H Decker
Journal:  Head Neck       Date:  2012-06-28       Impact factor: 3.147

3.  XPF knockout via CRISPR/Cas9 reveals that ERCC1 is retained in the cytoplasm without its heterodimer partner XPF.

Authors:  Janin Lehmann; Christina Seebode; Sabine Smolorz; Steffen Schubert; Steffen Emmert
Journal:  Cell Mol Life Sci       Date:  2017-01-27       Impact factor: 9.261

Review 4.  The ERCC1 and ERCC4 (XPF) genes and gene products.

Authors:  Mandira Manandhar; Karen S Boulware; Richard D Wood
Journal:  Gene       Date:  2015-06-12       Impact factor: 3.688

5.  Quantification of excision repair cross-complementing group 1 and survival in p16-negative squamous cell head and neck cancers.

Authors:  Ranee Mehra; Fang Zhu; Dong-Hua Yang; Kathy Q Cai; Joellen Weaver; Mahendra K Singh; Anna S Nikonova; Erica A Golemis; Douglas B Flieder; Harry S Cooper; Miriam Lango; John A Ridge; Barbara Burtness
Journal:  Clin Cancer Res       Date:  2013-10-02       Impact factor: 12.531

6.  High/positive expression of ERCC1 predicts poor treatment response and survival prognosis in nasopharyngeal carcinoma: A systematic meta-analysis from 21 studies.

Authors:  Lin Yang; Wenjie Wei; Lei Zhou; Jing Wang; Guangyuan Hu
Journal:  Medicine (Baltimore)       Date:  2019-05       Impact factor: 1.817

7.  Modulation of ERCC1-XPF Heterodimerization Inhibition via Structural Modification of Small Molecule Inhibitor Side-Chains.

Authors:  Claudia Weilbeer; David Jay; James C Donnelly; Francesco Gentile; Feridoun Karimi-Busheri; Xiaoyan Yang; Rajam S Mani; Yaping Yu; Ahmed H Elmenoufy; Khaled H Barakat; Jack A Tuszynski; Michael Weinfeld; Frederick G West
Journal:  Front Oncol       Date:  2022-03-17       Impact factor: 6.244

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.